Fanapt Oral Tablet 1-2-4-6Mg Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • myWeekly Ad

Fanapt: Oral tablet (1-2-4-6mg)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file DrugItem_19315.JPG
Fanapt Titration Pack
Novartis Pharmaceuticals Corp
Pill Identification: LOGO  |  1,2,4,6
Drug Image file DrugItem_19315.JPG
Fanapt Titration Pack
Novartis Pharmaceuticals Corp
Pill Identification: LOGO  |  1,2,4,6
Drug Image file DrugItem_19315.JPG
Fanapt Titration Pack
Novartis Pharmaceuticals Corp
Pill Identification: LOGO  |  1,2,4,6
Drug Image file DrugItem_19315.JPG
Fanapt Titration Pack
Novartis Pharmaceuticals Corp
Pill Identification: LOGO  |  1,2,4,6
Drug Image file DrugItem_19315.JPG
Fanapt Titration Pack
Novartis Pharmaceuticals Corp
Pill Identification: LOGO  |  1,2,4,6

What is this Medicine?

ILOPERIDONE (EYE loe PER i done) is an antipsychotic medicine. It is used to treat schizophrenia.

CVS Pharmacy Patient Statistics for Fanapt: Oral tablet(1-2-4-6mg)
Generic vs. Brand Name Usage*
*Brand contains same active ingredient but may not represent FDA-approved generic equivalent
Usage By Strength
In-Depth Information
Select a Medication

Fanapt Titration Pack

NDC: 000780602
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Schizophrenia

Sometimes used for but not FDA approved for the following conditions:
Agitation

Storage Information
Protect from light
Protect from moisture
Store at 77 degrees F; excursions permitted to 59-86 degrees F
Fanapt Titration Pack
Drug Image file DrugItem_19314.JPG
Novartis Pharmaceuticals Corp
Pill Identification: LOGO  |  1,2,4,6
Shape: round
Color: white
Drug Image file DrugItem_19313.JPG
Novartis Pharmaceuticals Corp
Pill Identification: LOGO  |  1,2,4,6
Shape: round
Color: white
Drug Image file DrugItem_17445.JPG
Novartis Pharmaceuticals Corp
Pill Identification: LOGO  |  1,2,4,6
Shape: round
Color: white
Drug Image file DrugItem_17328.JPG
Novartis Pharmaceuticals Corp
Pill Identification: LOGO  |  1,2,4,6
Shape: round
Color: white
Drug Image file DrugItem_19315.JPG
Novartis Pharmaceuticals Corp
Pill Identification: LOGO  |  1,2,4,6
Shape: round
Color: white

Reported Side Effects for Fanapt Titration Pack

High Body Temperature Incidence:
<0.1%*
Severity: MODERATE
Onset: DELAYED
High Triglycerides Incidence:
<10.1%*
Severity: MODERATE
Onset: DELAYED
Low Blood Pressure Incidence:
<3.0%*
Severity: MODERATE
Onset: RAPID
Gynecomastia Incidence:
<0.1%*
Severity: MILD
Onset: DELAYED
Prostate Infection Incidence:
<0.1%*
Severity: MODERATE
Onset: DELAYED
Restless Legs Syndrome (RLS) Incidence:
<0.1%*
Severity: MILD
Onset: DELAYED
Abnormal Heart Rhythm Incidence:
<0.1%*
Severity: SEVERE
Onset: EARLY
Mouth Ulcers Incidence:
<0.1%*
Severity: MODERATE
Onset: DELAYED
Decreased Breathing Incidence:
<0.1%*
Severity: SEVERE
Onset: DELAYED
Retaining Urine Incidence:
<0.1%*
Severity: MODERATE
Onset: EARLY
Low White Blood Cell Counts Incidence:
<0.1%*
Severity: MODERATE
Onset: DELAYED
Irregular Periods Incidence:
<0.1%*
Severity: MILD
Onset: DELAYED
Wryneck Incidence:
<0.1%*
Severity: SEVERE
Onset: DELAYED
Heart Block Incidence:
<0.1%*
Severity: SEVERE
Onset: EARLY
Kidney Failure Incidence:
<0.1%*
Severity: SEVERE
Onset: DELAYED
Stomach Ulcer Incidence:
<0.1%*
Severity: SEVERE
Onset: DELAYED
Shortness Of Breath Incidence:
<0.1%*
Severity: MODERATE
Onset: EARLY
Throat Inflammation Incidence:
<0.1%*
Severity: MODERATE
Onset: DELAYED
Heart Failure Incidence:
<0.1%*
Severity: SEVERE
Onset: DELAYED
Heavy Menstrual Period Incidence:
<0.1%*
Severity: MILD
Onset: DELAYED
Impulse Control Symptoms Incidence:
0.1-1.0%*
Severity: MODERATE
Onset: DELAYED
Increased Urination Incidence:
0.1-1.0%*
Severity: MILD
Onset: EARLY
Testicular Pain Incidence:
0.1-1.0%*
Severity: MILD
Onset: EARLY
Engorgement With Blood Incidence:
0.1-1.0%*
Severity: MODERATE
Onset: DELAYED
Convulsions Incidence:
0.1%*
Severity: SEVERE
Onset: DELAYED
Restlessness Incidence:
0.1-1.0%*
Severity: MILD
Onset: EARLY
Hostility Incidence:
0.1-1.0%*
Severity: MODERATE
Onset: EARLY
Loss Of Memory Incidence:
0.1-1.0%*
Severity: MODERATE
Onset: DELAYED
Excessive Thirst Incidence:
0.1-1.0%*
Severity: MILD
Onset: EARLY
Decreased Sexual Desire Incidence:
0.1-1.0%*
Severity: MILD
Onset: DELAYED
Fluid Retention Incidence:
0.1-1.0%*
Severity: MODERATE
Onset: DELAYED
Causing To Be Hungry Incidence:
0.1-1.0%*
Severity: MILD
Onset: DELAYED
Paresthesias Incidence:
0.1-1.0%*
Severity: MILD
Onset: DELAYED
Paranoia Incidence:
0.1-1.0%*
Severity: MILD
Onset: EARLY
Fecal Incontinence Incidence:
0.1-1.0%*
Severity: MODERATE
Onset: EARLY
Orgasm Dysfunction Incidence:
0.1-1.0%*
Severity: MILD
Onset: DELAYED
Mouth Sores Incidence:
0.1-1.0%*
Severity: MODERATE
Onset: DELAYED
Swollen Eyelids Incidence:
0.1-1.0%*
Severity: MILD
Onset: EARLY
Breathing Difficulties Incidence:
0.1-1.0%*
Severity: SEVERE
Onset: RAPID
Confusion Incidence:
0.1-1.0%*
Severity: MODERATE
Onset: EARLY
Dry Nose Incidence:
0.1-1.0%*
Severity: MILD
Onset: EARLY
Emotional Lability Incidence:
0.1-1.0%*
Severity: MILD
Onset: EARLY
Kidney Stones Incidence:
0.1-1.0%*
Severity: MODERATE
Onset: DELAYED
Breast Pain Incidence:
0.1-1.0%*
Severity: MILD
Onset: DELAYED
Mania Incidence:
0.1-1.0%*
Severity: MODERATE
Onset: EARLY
Underactive Thyroid Incidence:
0.1-1.0%*
Severity: MODERATE
Onset: DELAYED
Low Potassium Levels Incidence:
0.1-1.0%*
Severity: MODERATE
Onset: DELAYED
Extra Saliva Production Incidence:
0.1-1.0%*
Severity: MILD
Onset: EARLY
Inflamed Stomach Incidence:
0.1-1.0%*
Severity: MODERATE
Onset: DELAYED
Nose Bleed Incidence:
0.1-1.0%*
Severity: MILD
Onset: DELAYED
Swelling Incidence:
0.1-1.0%*
Severity: MODERATE
Onset: DELAYED
Painful Urination Incidence:
0.1-1.0%*
Severity: MODERATE
Onset: EARLY
Depression Incidence:
0.1-1.0%*
Severity: MODERATE
Onset: DELAYED
Delirium Incidence:
0.1-1.0%*
Severity: MODERATE
Onset: EARLY
Dehydration Incidence:
0.1-1.0%*
Severity: MODERATE
Onset: DELAYED
Gallstones Incidence:
0.1-1.0%*
Severity: MODERATE
Onset: DELAYED
Inflamed Eyes Incidence:
0.1-1.0%*
Severity: MODERATE
Onset: EARLY
Anemia Incidence:
0.1-1.0%*
Severity: MODERATE
Onset: DELAYED
No Menstrual Periods Incidence:
0.1-1.0%*
Severity: MILD
Onset: DELAYED
Cataracts Incidence:
0.1-1.0%*
Severity: MODERATE
Onset: DELAYED
Dry Eyes Incidence:
0.1-1.0%*
Severity: MILD
Onset: EARLY
Fast Eye Movements Incidence:
0.1-1.0%*
Severity: MODERATE
Onset: DELAYED
Eye Inflammation Incidence:
0.1-1.0%*
Severity: MODERATE
Onset: EARLY
Balance Problems Incidence:
0.1-1.0%*
Severity: MILD
Onset: EARLY
Ringing In Ears Incidence:
0.1-1.0%*
Severity: MILD
Onset: DELAYED
Runny Nose Incidence:
0.1-1.0%*
Severity: MILD
Onset: EARLY
Pseudoparkinsonism Incidence:
0.2-0.3%*
Severity: MODERATE
Onset: DELAYED
Fainting Incidence:
0.4%*
Severity: MILD
Onset: EARLY
Dystonic Reaction Incidence:
0.8-1.0%*
Severity: MODERATE
Onset: DELAYED
Weight Loss Incidence:
>1.0%*
Severity: MILD
Onset: DELAYED
Weight Gain Incidence:
1.0-9.0%*
Severity: MILD
Onset: DELAYED
Rapid Heart Rate Incidence:
>1.0%*
Severity: MODERATE
Onset: EARLY
Uncontrolled Urination Incidence:
>1.0%*
Severity: MODERATE
Onset: EARLY
Dyskinesia Incidence:
1.0-1.7%*
Severity: MODERATE
Onset: DELAYED
Muscle Pain Incidence:
>1.0%*
Severity: MILD
Onset: EARLY
Conjunctivitis Incidence:
>1.0%*
Severity: MODERATE
Onset: DELAYED
Blurred Vision Incidence:
1.0-3.0%*
Severity: MODERATE
Onset: EARLY
Impotence (erectile Dysfunction) Incidence:
>1.0%*
Severity: MODERATE
Onset: DELAYED
Tiredness Incidence:
1.0-3.0%*
Severity: MILD
Onset: EARLY
Increased Blood Fats Incidence:
1.1-10.1%*
Severity: MODERATE
Onset: DELAYED
High Cholesterol Incidence:
1.1-3.6%*
Severity: MODERATE
Onset: DELAYED
Restlessness Incidence:
1.7-2.3%*
Severity: MODERATE
Onset: DELAYED
Skin Rash Incidence:
2.0-3.0%*
Severity: MILD
Onset: EARLY
Ejaculation Dysfunction Incidence:
2.0%*
Severity: MODERATE
Onset: DELAYED
Shaking Incidence:
2.5-3.1%*
Severity: MILD
Onset: EARLY
Rapid Heart Rate Incidence:
3.0-12.0%*
Severity: MODERATE
Onset: RAPID
Joint Pain Incidence:
3.0%*
Severity: MILD
Onset: DELAYED
Postural Low Blood Pressure Incidence:
3.0-5.0%*
Severity: MODERATE
Onset: DELAYED
Tired Incidence:
4.0-6.0%*
Severity: MILD
Onset: EARLY
Loose Stools Incidence:
5.0-7.0%*
Severity: MILD
Onset: EARLY
Stuffy Nose Incidence:
5.0-8.0%*
Severity: MILD
Onset: EARLY
Upset Stomach Incidence:
7.0-10.0%*
Severity: MILD
Onset: EARLY
Dry Mouth Incidence:
8.0-10.0%*
Severity: MILD
Onset: EARLY
Drowsiness Incidence:
9.0-15.0%*
Severity: MILD
Onset: EARLY
Lightheadedness Incidence:
10.0-20.0%*
Severity: MILD
Onset: EARLY
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Daily Life Interactions for Fanapt Titration Pack

Elements of your daily lifestyle may have an effect on the medications you are taking. Drug interactions can result in unwanted side effects, reduce the effectiveness of your medicine or possibly increase the action of a particular medicine.

Major Lifestyle Interaction
Alcohol and Fanapt Titration Pack(Iloperidone)
Alcohol and CNS Depressants(Iloperidone)
Avoid alcohol-containing drinks while taking this medicine. Using this drug along with alcohol can lead to serious side effects. You may feel drowsy or more tired when taking these drugs together. Do not drive or operate machinery until you know how this drug affects you, and especially if you are drinking alcohol-containing beverages. If you notice slurred speech, confusion, severe weakness, or difficulty breathing, contact your health care provider immediately.
Pregnancy & Lactation Information
FIRST Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

SECOND Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

THIRD Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

Lactation

Avoid - This drug is known to cause harm to infants when taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Fanapt

Be the first to share your experience!

We want to help our customers stay educated about the medications they are taking. Submit your own observations and experiences to benefit others.

Average Scores
Easy to Take 
0 / 5
0 / 5
Works as Intended 
0 / 5
0 / 5
Tolerable 
0 / 5
0 / 5